Follow the 라파스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 라파스 has logged 82 reports. Market capitalisation: €73.5bn. The latest transaction was reported on 2 June 2026 (Purchase). Among the most active insiders: 정도현. All data is free.
82
Insider Decl.
n/a
Thresholds
€264,094
10 ops.
Buy Volume
n/a
37 ops.
Sell Volume
32Σ signal
Buys €264,094n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,749 of 29,062 companies
23.5
score / 100
Value
24
Quality
23
FCF yld1.0%
Earn yld-6.3%
EV/EBITDA35.1x
ROE-19%
Gross mgn45%
Net mgn-14%
Debt/EBITDA11.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
